Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle
- PMID: 35773050
- DOI: 10.1016/j.hoc.2022.03.004
Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle
Abstract
The recent progress in gene and gene-modified cellular therapies has shown great promise for numerous pediatric diseases. Nevertheless, the development of these products is complicated, and the regulatory pathway is rigorous. There are, however, several opportunities for programmatic support within the Food and Drug Administration. This article highlights the life cycle of product development through approval and many of the available resources and programs to support product development.
Keywords: Cell therapy; Food and drug administration (FDA); Gene therapy; Pediatric; Regulations.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
